Fresenius Kabi's approved generic therapy addresses acute symptomatic hypocalcemia and targets a US market valued at nearly $71 million
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
Health innovations are viewed more positively than food and agricultural technologies
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
Subscribe To Our Newsletter & Stay Updated
